Diagnosis of laryngopharyngeal reflux

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 3, 2004, Pages 174-179

  Tutuian, Radu ^a   Castell, Donald O ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Gastroesophageal reflux disease; Laryngopharyngeal reflux; PH testing; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DRUG MEGADOSE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOPHARYNX; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; PH MEASUREMENT; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SYMPTOMATOLOGY;

ANTACIDS; ANTI-ULCER AGENTS; DIAGNOSIS, DIFFERENTIAL; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYPOPHARYNX; LARYNGEAL DISEASES; PROTON PUMPS; VOICE DISORDERS;

EID: 2542453272     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000120303.58882.5a     Document Type: Review

References (29)

1. Koufman JA: The otolaryngologic manifestation of gastroesophageal reflux disease. Laryngoscope 1991, 101:1-78,
2. Fraser AG: Gastroesophageal reflux and laryngeal symptoms. Aliment Pharmacol Ther 1994, 8:265-272.
3. Koufman JA, Wiener GJ, Wallace CW, et al.: Reflux laryngitis and its sequelae. J Voice 1988, 2:78-79.
4. Richter JE: Typical and atypical presentation of gastroesophageal reflux disease. Gastroenterol Clin North Am 1996, 25:75-102.
5. Jaspersen D, Kulig M, Labenz J, et al.: Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003, 17:1515-1520. This is a large population-based study describing the prevalence of ENT manifestations in patients with GERD.
6. Gaynor EB: Otolaryngologic manifestations of gastroesophageal reflux. Am J Gastroenterol 1991, 86:801-808.
7. Vaezi MF: Gastroesophageal reflux disease and the larynx. J Clin Gastroenterol 2003, 36:198-203. This is an excellent review article of ENT manifestations in GERD.
8. Vaezi MF: Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence. Am J Med 2003, 115:97S-104S.
9. Belafsky PC, Postma GN, Koufman JA: Validity and reliability of the reflux symptom index (RSI). J Voice 2002, 16:274-277.
10. Belafsky PC, Postma GN, Koufman JA: The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001, 111:1313-1317.
11. Belafsky PC: Abnormal endoscopic pharyngeal and laryngeal findings attributable to reflux. Am J Med 2003, 115:90S-96S.
12. Hicks DM, Ours TM, Abelson TI, et al.: The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002, 16:564-579. This is an excellent study identifying the poor specificity of hypopharyngeal signs thought to be the result of reflux.
13. Oelschlager BK, Eubanks TR, Hillel A, et al.: Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageal-laryngeal reflux. J Gastrointest Surg 2002, 6:189-194.
14. Bardan E. Pharyngoesophageal pH monitoring. Am J Med 2003, 115(suppl 3A):78S-80S.
15. Dobhan R, Castell DO: Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 1993, 88:25-29.
16. Vaezi MF, Schroeder PL, Richter JE: Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 1997, 92:825-829.
17. Katz PO: Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness. Am J Gastroenterol 1990, 85:38-40.
18. Shaker R, Milbrath M, Ren J, et al.: Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995, 109:1575-1582.
19. Bove M, Ruth M, Cange L, et al.: 24-H pharyngeal pH monitoring in healthy volunteers: a normative study. Scand J Gastroenterol 2000, 35:234-241.
20. Maldonado A, Diederich L, Castell DO, et al.: Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts. Laryngoscope 2003, 113:349-355.
21. Noordzij JP, Khidr A, Desper E, et al.: Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002, 112:2192-2195.
22. Tutuian R, Castell DO: Use of multichannel intraluminal impedance (MII) to document proximal esophageal and pharyngeal non-acidic reflux events. Am J Med 2003, 115:119-123.
23. Shay SS, Tutuian R, Sifrim D, et al.: Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004, in press.
24. Tutuian R, Vela MF, Shay SS, et al.: Multichannel intraluminal impedance (MII) in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003, 37:206-215.
25. Siupsinskiene N, Adamonis K: Diagnostic test with omeprazole in patients with posterior laryngitis. Medicina (Mex) 2003, 39:47-55.
26. DeGaudio JM, Waring JP: Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 2003, 113:598-601.
27. Noordzij JP, Khidr A, Evans BA, et al.: Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001, 111:2147-2151.
28. Eherer AJ, Habermann W, Hammer HF, et al.: Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003, 38:462-467. This is an excellently designed but unfortunately underpowered study comparing high-dose PPI versus placebo in diagnosing LPR.
29. Kamel PL, Hanson D, Kahrilas PJ: Omeprazole for the treatment of posterior laryngitis. Am J Med 1994, 96:321-326.